Hasil Pencarian  ::  Simpan CSV :: Kembali

"Asupan serat pada penyandang DM tipe 2 maupun orang sehat di Indonesia rendah, meskipun berbagai penelitian membuktikan bahwa serat bermanfaat dalam memperbaiki profil lipid. Uji klinis acak menyilang ini bertujuan mengetahui pengaruh penambahan serat makanan terhadap profil lipid penyandang DM tipe 2 usia 20−64 tahun, dengan kadar serum kolesterol total >150 mg/dL, atau kolesterol LDL >100 mg/dL, atau kadar HDL < 45 mg/dL, atau trigliserida >150 mg/dL. Setiap subyek penelitian menjalani dua macam perlakuan diet selama 3 minggu, dengan wash out selama 1 minggu: diet DM sesuai rekomendasi PERKENI dengan makanan selingan berserat 5,88 g/hari. Dilakukan wawancara karakteristik demografi, pengukuran tinggi dan berat badan, penilaian asupan zat gizi dengan metode food record 3 x 24 jam serta pemeriksaan profil lipid sebelum dan setelah perlakuan. Rentang usia subyek penelitian 47-61 tahun, sebagian besar subyek adalah perempuan, dan tingkat pendidikan rendah, serta tingkat aktivitas fisik ringan, dengan status gizi obes I sebanyak 66%. Subyek dapat mengonsumsi makanan selingan berserat sebanyak 90% dari anjuran. Makanan selingan berserat dapat ditoleransi dengan baik, tanpa ada keluhan yang berarti. Sebagian besar subyek penelitian tidak dapat mengikuti anjuran diet DM nya, terutama dalam hal asupan protein, lemak, dan serat. Terlihat penurunan yang bermakna pada kadar serum kolesterol total (p=0,03) dan trigliserida (p=0,04) setelah konsumsi makanan selingan berserat. Kesimpulan: diet DM dengan konsumsi serat sebagai makanan selingan sebesar 5,88 g/hari menurunkan kadar serum kolesterol total dan trigliserida serum dibandingkan dengan diet DM pada penyandang DM tipe 2. Penelitian lanjutan dianjurkan dengan menambah serat dalam makanan selingan.

---

Dietary fiber intake of type 2 Diabetes Mellitus (T2DM) patients and general Indonesian population were lower than recommendation, despite proven beneficial effect of dietary fiber on serum lipid profile. This randomized cross-over clinical trial aims to investigate the effect of 5,88 g/day fiber snack supplementation for 3 weeks on serum lipid profile among 20−64 years old T2DM patients with either serum concentration cholesterol total >150 mg/dL, cholesterol LDL >100 mg/dL, cholesterol HDL <45 mg/dL, or triglyceride >150 mg/dL.

Every subject underwent two treatments for 3 weeks with 1 week wash out: 5.88 g/day dietary fiber in snack bars integrated in diabetic diet recommended by Indonesian Diabetic Association (PERKENI). Assessments of sociodemographic, body height and weight, dietary intake using food record 3x24 hours method during study period, and lipid profile before and after intervention were performed.

Subjects age ranged 47-61 years, majority was female, low educational level, sedentary physical activity, and 66% obese. Subjects managed to consume 90% of the dietary fiber snack bars, without experiencing any side effects. Majority of subjects could not follow their diabetic dietary regimen, especially consumption of protein, fat and fiber. There were significant decreases total cholesterol (p=0.03) and triglyceride (p=0.04) serum concentrations after consumption of dietary fiber in snack bars.

Conclusion : diabetic diet with 5.88 g/day fiber snack decreases total cholesterol and triglyceride serum concentrations compared to diabetic diet alone in patients with T2DM. Further study to increase the amount of fiber in snack is proposed."

"Asupan serat dalam menu harian penyandang diabetes masih rendah. Tujuan penelitian ini adalah mengetahui pengaruh penambahan serat dalam makanan selingan penyandang diabetes melitus (DM) 2 terhadap kadar glukosa darah. Penelitian ini merupakan studi eksperimental dengan desain menyilang alokasi acak pada 7 laki-laki dan 13 perempuan di Klinik Dokter Keluarga Kayu Putih Jakarta. Subyek penelitian dibagi dalam dua kelompok: kelompok kontrol mendapat anjuran diet DM dan kelompok perlakuan mendapat anjuran diet DM dan pemberian makanan selingan yang mengandung serat 6 gram/hari selama 3 minggu. Pemeriksaan kadar glukosa darah puasa dan 2 jam postprandial dilakukan pada awal dan akhir perlakuan. Status gizi obes didapatkan pada 55% subyek. Sebagian besar subyek tidak mematuhi anjuran diet DM: asupan lemak tinggi sedangkan asupan serat 7,0–13,7 g/hari. Pada awal penelitian, kadar glukosa darah puasa dan 2 jam postprandial serum kedua kelompok perlakuan tidak berbeda bermakna. Setelah periode perlakuan, perubahan kadar glukosa darah tidak bermakna, namun terlihat cenderung menurun pada kelompok perlakuan. Kesimpulan: pada penyandang DM tipe 2, pemberian makanan selingan yang mengandung serat 6 gram selama 3 minggu tidak menurunkan kadar glukosa darah puasa dan 2 jam postprandial serum.

---

Fiber intake in the daily menu of diabetes patients was observed to be lower than recommendation. The aim of this study was to evaluate the effect of fiber supplementation as snack on blood glucose levels in type 2 diabetic subjects. This randomized, cross-over controlled clinical trial involved 7 men and 13 women, who visited to Family Doctor Clinic Kayu Putih in Jakarta. Subjects were assigned into two groups: control group who got diabetic diet recommendation, while treatment group got diabetic diet recommendation and snack containing 6 grams fiber/day for three weeks. Fasting blood glucose (FBG) and 2 hours postprandial blood glucose (PPBG) levels were assessed before and after intervention. Fifty five percent of the subjects were obese. Majority of subjects could not comply with diabetic regiment: high in fat, while fiber intakes was around 7.0–13.7 g/day. At baseline, FBG and PPBG levels were comparable. After intervention period, blood glucose level did not changed significantly, but tend to decrease in the treatment group. In conclusion: snack containing 6 grams of fiber for three weeks did not decrease FBG and PPBG of type 2 diabetic subjects."

"Sambiloto (Andrographis paniculata Nees.) secara empiris telah digunakan sebagai obat alternatif untuk berbagai penyakit termasuk diabetes mellitus. Penelitian ini dilakukan untuk menganalisis efek hipoglikemik kapsul sambiloto sebagai terapi tambahan pada penyandang diabetes melitus tipe 2. Double-blind randomized controlled trial cross-over desain pada 34 subyek dibagi menjadi dua kelompok. Kelompok pertama sambiloto mendapat 2 kali 2 kapsul sehari selama 14 hari, dan kelompok kedua mendapat plasebo selama 14 hari. Kedua kelompok tetap menggunakan metformin sebagai terapi standar kemudian dievaluasi kadar glukosa darah pasca terapi 14 hari. Pada pemberian kapsul sambiloto selama 14 hari tampak penurunan kadar glukosa darah puasa lebih besar dibandingkan plasebo, tetapi tidak bermakna. Kapsul sambiloto bermakna menurunkan kadar glukosa darah 2 jam setelah makan. Kesimpulan: Kapsul sambiloto dapat menurunkan kadar glukosa darah namun bermakna secara statistik hanya 2 jam setelah makan.

---

Sambiloto (Andrographis paniculata Nees.) is empirically used as an alternative medicine for various diseases including diabetes mellitus, but the scientific evident for treatment in humans is still limited. This study analyze the effects of hypoglycemic sambiloto capsules as additional therapy in patients with type 2 diabetes mellitus. Double-blind randomized controlled trial, cross-over design in 34 subjects who were divided into two groups. The first groups sambiloto received 2 capsules 2 times daily for 14 days, and the second groups received placebo for 14 days. Both groups kept taking metformin as standard therapy with an the evaluation of blood glucose levels on day 14. The results showed that administration of sambiloto capsules for 14 days, the blood glucose levels is greater compared to placebo but not significantly. Sambiloto capsules significantly reduced blood glucose 2 hours after eating. Conclusions: sambiloto capsules shown to reduced blood glucose levels, but statistically significant only in 2 hours after eating."

"Penelitian ini bertujuan untuk mengetahui hubungan antara profil lipid darah dengan derajat retinopati diabetik penderita DM tipe-2. Penelitian potong-lintang pada 52 pasien retinopati diabetika dilaksanakan di Poliklinik Mata, Rumah Sakit Cipto Mangunkusumo, Jakarta. Data yang dikumpulkan meliputi data demografi, gaya hidup, lama menderita DM, pemeriksaan fisik dan antropometrik, asupan lemak, asam lemak dan kolesterol data kadar gula darah puasa, A1C, kolesterol total, kolesterol-LDL, kolesterol-HDL and trigliserida, dan pemeriksaan fundus. Analisis statistik yang digunakan adalah uji chi-square untuk mengetahui hubungan antara profil lipid darah dengan derajat retinopati diabetik. Subyek terdiri dari 20 orang laki-laki dan 32 orang perempuan dengan rerata usia 53,8 ± 5,2 tahun. Sebanyak 53,8% telah didiagnosis DM selama >10 tahun, dengan rerata IMT adalah 24,1 ± 3,3 kg/m2 dan 38,5% diklasifikasikan sebagai obes I dan II. Rerata kadar gula darah puasa 157,5 ± 71,8 mg/dL, dan A1C 9,1 ± 2,4 %. Sebanyak 40,4% subyek mempunyai kadar kolesterol total darah tinggi, 34,6% kadar kolesterol-LDL darah sangat tinggi, dan 65,4% dengan kolesterol-HDL dan trigliserida darah normal. Derajat keparahan retinopati diabetika ditunjukkan dengan adanya 61,6% subyek dengan retinopati diabetika non-proliferasi berat (NPDR) and retinopati diabetika proliferasi (PDR). Kesimpulannya, belum dapat dibuktikan adanya hubungan yang bermakna antara profil lipid dengan derajat retinopati diabetika.

---

This study aimed to determine the relationship between plasma lipid profile and the severity of diabetic retinopathy in type 2 diabetes patients. A cross sectional study was done in Ophthalmologic Clinic, Cipto Mangunkusumo General Hospital, Jakarta for 52 diabetic retinopathy (DR) patients. Data collected were demographic, life style, duration of diabetes, physical and antropometric examinations, fat, fatty acid and cholesterol intake, fasting plasma glucose, A1C, total-, LDL-, HDL-cholesterol and triglyceride level, and fundus examination.

Statistical analysis was done using chi-square test to see the associations between plasma lipid profile and DR in type 2 diabetes patients. Subjects comprised of 20 males and 32 females diabetes patients with mean age of 53.8 ± 5.2 years. As much as 53.8% had been diagnosed as DM for >10 years. The mean value of BMI was 24.1 ± 3.3 kg/m2 and 38.5% were classified as obese I and II. The mean value of fasting plasma glucose was 157.5 ± 71.8 mg/dL, and A1C was 9.1 ± 2.4 %.

For lipid profile, 40.4% had high total cholesterol level (>240 mg/dL), 34.6% had high and very high LDL-cholesterol level (≥160 mg/dL), and 65.4% had normal HDL-cholesterol (40-60 mg/dL) and triglyceride level (<150 mg/dL). For the severity of retinopathy, 61.6% had severe non-proliferative diabetic retinopahy (NPDR) and proliferative diabetic retinopahy (PDR). In conclusion, there were no significant associations between plasma lipid profile and the severity of diabetic retinopathy."

"ABSTRAK Latar Belakang. Prevalensi disfungsi tiroid lebih tinggi pada pasien diabetes dibandingkan populasiumum. Hipotiroidisme memperburuk komplikasi, morbiditas, mortalitas, dan kualitas hidup pasiendiabetes melitus tipe 2 (DM tipe 2). Faktor risiko hipotiroidisme pada pasien DM tipe 2 selama ini masihkontradiktif dan belum dikaji secara lengkap. Keberadaan sistem skor hipotiroidisme pada pasien DMtipe 2 diperlukan untuk membantu diagnosis dan menapis pasien DM tipe 2 yang memerlukanpemeriksaan laboratorium fungsi tiroid sebagai baku emas diagnosis hipotiroidisme.Tujuan. Mengetahui prevalensi dan determinan hipotiroidisme pada pasien DM tipe 2.Metode. Penelitian dengan desain potong lintang dilakukan di Poliklinik Divisi Metabolik Endokrin(Poliklinik Diabetes) RSCM pada Juli sampai September 2015 dengan metode sampling konsekutif.Subjek menjalani anamnesis, pemeriksaan fisis, dan pemeriksaan laboratorium (TSH dan fT4). Analisisdata dilakukan dengan program statistik SPSS Statistics 17.0 untuk analisis univariat, bivariat,multivariat, dan Receiving Characteristics Operator (ROC) dan SPSS Statistics 20.0 untuk analisisbootstrapping pada Kalibrasi Hosmer-Lemeshow.Hasil. Sebanyak 303 subjek dianalisis untuk mendapatkan proporsi disfungsi tiroid dan 299 subjekdianalisis untuk mendapatkan determinan hipotiroidisme. Sebanyak 23 subjek (7,59%) terdiagnosishipotiroidisme, terdiri dari 43,5% subjek hipotiroid klinis dan 56,5% subjek hipotiroid subklinisberdasarkan Indeks Zulewski dan/atau Indeks Billewicz, dengan 16,7% hipotiroid klinis dan 83,3%hipotiroid subklinis berdasarkan hasil pemeriksaan fT4. Determinan hipotiroidisme pada pasien DMtipe 2 adalah riwayat penyakit tiroid di keluarga dengan OR sebesar 4,719 (95% IntervalKepercayaan/IK 1,07-20,8, p = 0,04), keberadaan goiter dengan OR sebesar 20,679 (95% IK 3,49122,66, p = 0,001),kontrol glikemik yang buruk dengan OR sebesar 3,460 (95%IK 1,075-11,14, p = 0,037), dan adanya sindrom metabolikOR sebesar 25,718 (95% IK 2,21-299,99, p = 0,01). Simpulan. Proporsi hipotiroidisme pada pasien DM tipe 2 adalah 7,59%. Determinan diagnosis dan komponen sistem skor hipotiroidisme pada pasien DM tipe 2 adalah riwayat penyakit tiroid di keluarga, keberadaan goiter, kontrol glikemik yang buruk, dan adanya sindrom metabolik. Sistem skor yang diberi nama Skor Hipotiroid RSCM ini diharapkan menjadi alat bantu diagnosis hipotiroidisme pada pasienDM tipe 2. ABSTRACT Background. Prevalence of thyroid dysfunction is greater in diabetes patients compared to generalpopulation. Hypothyroidism is worsening complications, morbidity, mortality, and quality of life in type2 diabetes mellitus (T2DM) patients. Risk factors of hypothyroidism in T2DM patients are stillcontradictive and not assessed completely. Presence of scoring system to estimate hypothyroidism inT2DM patients are needed to help diagnosing and screening of T2DM patients who need to undergothyroid function test as a gold standard diagnostic for hypothyroidism.Aim. To identify prevalence and estimators of hypothyroidism in T2DM patients.Methods. A cross-sectional study was conducted in Metabolic Endocrine (Diabetes) Outpatient ClinicCipto Mangunkusumo Hospital from July-September 2015 with consecutive sampling method. Allsubjects underwent interview, physical examination, and laboratory testing (TSH and fT4). Analysiswas done by using SPSS Statistics 17.0 for univariate, bivariate, multivariate, and ROC (ReceivingOperator Characteristics) analysis and SPSS Statistics 20.0 for bootstrapping analysis in HosmerLemeshowCalibration. Results. 303 subjects included for proportion study of thyroid dysfunction and 299subjects included for analysis of hypothyroidism determinants. 23 subjects (7,59%) are diagnosed as havinghypothyroidism, consisted of 43,5% clinical hypothyroidism and 56,5% subclinical hypothyroidismbased on clinical scoring index by Zulewski and Billewicz, and 16,7% subjects as having clinicalhypothyroidism and 83,3% subjects as having subclinical hypothyroidism based on fT4 examination.Determinants for hypothyroidism in T2DM patients are family history of thyroid disease with OR 4,719(95% Confident Interval/CI 1,07-20,8, p = 0,04), having goiter or difus struma with OR 20,679 (95%CI 3,49-122,66, p = 0,001), poor glycemic control with OR 3,460 (95% CI 1,075-11,14, p = 0,037), and metabolic syndrome with OR 25,718 (95% CI 2,21-299,99, p = 0,01). Conclusion. Proportion of hypothyroidism in T2DM patients is 7,59%. Determinants and componentsof scoring system of hypothyroidism in T2DM patients consist of family history of thyroid disease,having goiter or difus struma, poor glycemic control, and metabolic syndrome. Scoring system which iscalled RSCM Hypothyroid Score is expected to be a tool for helping diagnosis of hypothyroidism inT2DM patients.;Background. Prevalence of thyroid dysfunction is greater in diabetes patients compared to generalpopulation. Hypothyroidism is worsening complications, morbidity, mortality, and quality of life in type2 diabetes mellitus (T2DM) patients. Risk factors of hypothyroidism in T2DM patients are stillcontradictive and not assessed completely. Presence of scoring system to estimate hypothyroidism inT2DM patients are needed to help diagnosing and screening of T2DM patients who need to undergothyroid function test as a gold standard diagnostic for hypothyroidism.Aim. To identify prevalence and estimators of hypothyroidism in T2DM patients.Methods. A cross-sectional study was conducted in Metabolic Endocrine (Diabetes) Outpatient ClinicCipto Mangunkusumo Hospital from July-September 2015 with consecutive sampling method. Allsubjects underwent interview, physical examination, and laboratory testing (TSH and fT4). Analysiswas done by using SPSS Statistics 17.0 for univariate, bivariate, multivariate, and ROC (ReceivingOperator Characteristics) analysis and SPSS Statistics 20.0 for bootstrapping analysis in HosmerLemeshowCalibration. Results.303subjectsincludedforproportionstudyofthyroiddysfunctionand299subjectsincludedforanalysis of hypothyroidism determinants. 23 subjects (7,59%) are diagnosed as havinghypothyroidism, consisted of 43,5% clinical hypothyroidism and 56,5% subclinical hypothyroidismbased on clinical scoring index by Zulewski and Billewicz, and 16,7% subjects as having clinicalhypothyroidism and 83,3% subjects as having subclinical hypothyroidism based on fT4 examination.Determinants for hypothyroidism in T2DM patients are family history of thyroid disease with OR 4,719(95% Confident Interval/CI 1,07-20,8, p = 0,04), having goiter or difus struma with OR 20,679 (95%CI 3,49-122,66, p = 0,001), poor glycemic control with OR 3,460 (95% CI 1,075-11,14, p = 0,037), and metabolic syndrome with OR 25,718 (95% CI 2,21-299,99, p = 0,01).Conclusion. Proportion of hypothyroidism in T2DM patients is 7,59%. Determinants and componentsof scoring system of hypothyroidism in T2DM patients consist of family history of thyroid disease,having goiter or difus struma, poor glycemic control, and metabolic syndrome. Scoring system which iscalled RSCM Hypothyroid Score is expected to be a tool for helping diagnosis of hypothyroidism inT2DM patients.;Background. Prevalence of thyroid dysfunction is greater in diabetes patients compared to generalpopulation. Hypothyroidism is worsening complications, morbidity, mortality, and quality of life in type2 diabetes mellitus (T2DM) patients. Risk factors of hypothyroidism in T2DM patients are stillcontradictive and not assessed completely. Presence of scoring system to estimate hypothyroidism inT2DM patients are needed to help diagnosing and screening of T2DM patients who need to undergothyroid function test as a gold standard diagnostic for hypothyroidism.Aim. To identify prevalence and estimators of hypothyroidism in T2DM patients.Methods. A cross-sectional study was conducted in Metabolic Endocrine (Diabetes) Outpatient ClinicCipto Mangunkusumo Hospital from July-September 2015 with consecutive sampling method. Allsubjects underwent interview, physical examination, and laboratory testing (TSH and fT4). Analysiswas done by using SPSS Statistics 17.0 for univariate, bivariate, multivariate, and ROC (ReceivingOperator Characteristics) analysis and SPSS Statistics 20.0 for bootstrapping analysis in HosmerLemeshowCalibration. Results.303subjectsincludedforproportionstudyofthyroiddysfunctionand299subjectsincludedforanalysis of hypothyroidism determinants. 23 subjects (7,59%) are diagnosed as havinghypothyroidism, consisted of 43,5% clinical hypothyroidism and 56,5% subclinical hypothyroidismbased on clinical scoring index by Zulewski and Billewicz, and 16,7% subjects as having clinicalhypothyroidism and 83,3% subjects as having subclinical hypothyroidism based on fT4 examination.Determinants for hypothyroidism in T2DM patients are family history of thyroid disease with OR 4,719(95% Confident Interval/CI 1,07-20,8, p = 0,04), having goiter or difus struma with OR 20,679 (95%CI 3,49-122,66, p = 0,001), poor glycemic control with OR 3,460 (95% CI 1,075-11,14, p = 0,037), and metabolic syndrome with OR 25,718 (95% CI 2,21-299,99, p = 0,01).Conclusion. Proportion of hypothyroidism in T2DM patients is 7,59%. Determinants and componentsof scoring system of hypothyroidism in T2DM patients consist of family history of thyroid disease,having goiter or difus struma, poor glycemic control, and metabolic syndrome. Scoring system which iscalled RSCM Hypothyroid Score is expected to be a tool for helping diagnosis of hypothyroidism inT2DM patients."

"Obat antidiabetes yang paling banyak diresepkan di Puskesmas Indonesia adalah metformin atau kombinasi metformin dan sulfonilurea. Studi tentang metformin telah menunjukkan berbagai dampak penurunan kognitif pada pasien dengan diabetes mellitus tipe 2, sedangkan sulfonilurea telah terbukti mengurangi dampak ini. Penelitian ini bertujuan untuk membandingkan dampak metformin dan metformin-sulfonilurea pada fungsi kognitif dan menentukan faktor apa yang mempengaruhinya. Studi potong lintang ini dilakukan di Puskesmas Pasar Minggu dengan melibatkan 142 pasien diabetes melitus tipe 2 yang mengonsumsi metformin atau metformin-sulfonilurea selama >6 bulan dan usia >36 tahun. Fungsi kognitif dinilai menggunakan kuesioner Montreal Cognitive Assessment versi bahasa Indonesia. Efek dari metformin dan metformin-sulfonylurea pada penurunan kognitif tidak menunjukkan perbedaan yang signifikan, bahkan setelah mengontrol kovariat (aOR = 1,096; 95% CI =  13.008px;">0,523–2,297; nilai-p = 0,808). Analisis multivariat menunjukkan usia (OR = 4,131; 95% CI = 1,271–13,428; nilai-p = 0,018) dan pendidikan (OR = 2,746; 95% CI = 1.196–6.305; nilai-p = 0,017) mempengaruhi fungsi kognitif. Pendidikan yang lebih rendah dan usia yang lebih tua cenderung menyebabkan penurunan kognitif, tenaga kesehatan didorong untuk bekerja sama dengan ahli kesehatan masyarakat untuk mengatasi faktor risiko fungsi kognitif ini.

---

The most prescribed antidiabetic drugs in Indonesian primary health care are metformin or a combination of metformin and sulfonylurea. Studies on metformin have shown various impacts on cognitive decline in patients with type 2 diabetes mellitus, whereas sulfonylurea has been shown to reduce this impact. This study aimed to compare the impacts of metformin and metformin-sulfonylurea on cognitive function and determine what factors affected it. This crosssectional study was conducted at Pasar Minggu Primary Health Care involving 142 type 2 diabetes mellitus patients taking metformin or metformin-sulfonylurea for >6 months and aged >36 years. Cognitive function was assessed using the validated Montreal Cognitive Assessment Indonesian version. The effects of metformin and metformin-sulfonylurea on cognitive decline showed no significant difference, even after controlling for covariates (aOR = 1.096; 95% CI = 0.523–2.297; p-value = 0.808). Multivariate analysis showed age (OR = 4.131; 95% CI = 1.271–13.428; p-value = 0.018) and education (OR = 2.746; 95% CI = 1.196–6.305; p-value = 0.017) affected cognitive function. Since a lower education and older age are likely to cause cognitive decline, health professionals are encouraged to work with public health experts to address these risk factors for cognitive function."

"Latar Belakang: Akumulasi lemak viseral pada pasien Diabetes Mellitus (DM) Tipe 2 dapat menyebabkan komplikasi metabolik dan risiko penyakit kardiovaskular. Tujuan: Penelitian ini bertujuan untuk mengetahui pengaruh latihan dalam bentuk kombinasi High Intensity Interval Training (HIIT) dan latihan beban terhadap perubahan lemak viseral pada pasien DM Tipe 2. Metode: Analisis sekunder dari Randomized Controlled Trial (RCT) pada bulan Juli 2017 sampai Januari 2018. Subjek berjumlah 18 orang yang diambil dari kelompok eksperimen. Subjek melakukan HIIT sebanyak 3x/minggu dan latihan beban 2x/minggu dengan durasi 12 minggu latihan. Protokol HIIT dengan perbandingan 1 menit intensitas tinggi dan 4 menit intensitas lebih rendah, sedangkan latihan beban terdiri dari 9 jenis latihan meliputi ekstrimitas atas, batang tubuh, dan ekstrimitas bawah. Hasil: 18 pasien (72% perempuan) dengan rerata usia 50,94 tahun. Seluruh subjek berada pada kategori overweight (17%), dan obese (83%), serta obesitas sentral (100%). Tidak didapatkan perubahan lemak viseral yang signifikan (p>0.05) dengan pengukuran menggunakan Bioelectrical Impedance Analysis (BIA). Kesimpulan: Didapatkan seluruh subjek berada pada kategori overweight dan obese serta memiliki obesitas sentral. Tidak didapatkan perubahan lemak viseral yang bermakna dari kombinasi HIIT dan latihan beban selama 12 minggu pada pasien DM Tipe 2.

---

Background: The accumulation of visceral fat in Type 2 Diabetes Mellitus patient can cause metabolic complications and risk of cardiovascular disease. Goals: This study aims to determine the effect of combined High Intensity Interval Training (HIIT) and Resistance training on the Changes in Visceral Fat in Type 2 Diabetes Mellitus Patient. Methods: Secondary analysis of the Randomized Controlled Trial (RCT) on July 2017 and completed January 2018. Eighteen participants were taken from the experimental group. Participants did HIIT three times a week and resistance training twice a week with the duration of 12 weeks. HIIT protocol was comprised of one minute of high intensity and 4 minutes of lower intensity. Resistance training was comprised of nine exercises for upper extremities, core, and lower extremities. Results: 18 patients (72% female) with an average age of 50.94 years. All subjects were in the overweight (17%), obese (83%), and central obesity (100%). There were no significant changes in visceral fat (p>0,05) with measurements using Bioelectrical Impedance Analysis (BIA). Conclusion: All participants are overweight, obese and have central obesity. There were no changes in visceral fat from a combination of HIIT and resistance training in

Type 2 DM patients in 12 weeks."

"Latar Belakang: Prevalensi Diabetes Melitus (DM) tipe 2 cenderung meningkat di seluruh dunia dan keteraturan pengobatan masih menjadi masalah hingga saat ini. Penelitian terdahulu menemukan bahwa terdapat hubungan antara temperamen dengan kontrol glukosa namun belum banyak penelitian yang membahas hal ini. Penelitian ini bertujuan mengetahui hubungan antara temperamen dengan terkontrol atau tidak terkontrolnya DM tipe 2.Metode: Penelitian ini adalah penelitian analitik potong lintang. Pengambilan sampel dilakukan dengan consecutive sampling pada 110 penyandang DM tipe 2 di Poliklinik Metabolik Endokrin RSCM selama bulan Agustus-Desember 2015. Responden dikelompokkan menjadi penyandang DM terkontrol atau DM tidak terkontrol berdasarkan hasil laboratorium HbA1c terakhir. Responden mengisi kuesioner Modified-Temperament and Character Inventory versi bahasa Indonesia.Hasil: Hasil penelitian ini menunjukkan bahwa skor temperamen harm avoidance, novelty seeking, dan reward dependence tidak berhubungan bermakna dengan terkontrol atau tidak terkontrolnya DM tipe 2.Simpulan: Tidak ada hubungan bermakna antara temperamen dengan pengendalian kadar HbA1c pada penyandang DM tipe 2.

---

Background: Prevalence on type 2 Diabetes Mellitus (DM) tend to increase across the world and regulating treatment still being one of the matters to be discussed until recently. Previous research had found that there are correlations between temperament with glucose control but with limited study on that area. This research aim to qualify the relationship between temperament to controllable or uncontrollable type 2 DM.

Method: This research is a cross sectional sampling method. Sampling conducted with consecutive sampling on 110 respondents with type 2 DM in RSCM Metabolism Endocrine Polyclinic, sampling was done between August to December 2015. Respondents are grouped to two different groups which is controllable DM and uncontrollable DM based on last HbA1c laboratory results. Respondents were requested to fill up Modified-Temperament and Character Inventory questionnaire in Bahasa Indonesia.

Results: Result on this research indicates that temperament score in harm avoidance, novelty seeking, and reward dependence are unrelated with whether Type 2 DM being controllable or uncontrollable.

Conclusion: Absent of significant relation between temperament and HbA1c level control in type 2 DM patients."

"[TUJUAN: Tujuan penelitian ini adalah membandingkan performa uji jalan 400 meter pada wanita antara penyandang diabetes melitus (DM) tipe 2 dan individu sehat, dengan membandingkan kecepatan berjalan dan prediksi ambilan oksigen maksimal (VO2max). METODE: Subyek penelitian adalah wanita dengan DM tipe 2 dan individu sehat, yang dipasangkan berdasarkan kelompok umur. Dilakukan pemeriksaan awal berupa indeks massa tubuh, glukosa sewaktu, ankle-brachial index, tekanan darah, dan nadi pra uji latih. Sebelum diberikan uji jalan 400 meter, subyek melakukan pemanasan pada jalur 20 meter selama 2 menit. Selama pemanasan dan uji latih, nadi diukur tiap 30 detik. Tekanan darah sistolik diukur setelah pemanasan dan dalam 60 detik setelah uji latih. Uji jalan 400 meter dilakukan 2 kali pada hari yang berbeda.

---

OBJECTIVE: The purpose of this study was to compare the performa of the 400-meter walk test in women between people with type 2 diabetes mellitus (DM) and healthy individuals, by comparing walking speed and predicted maximum oxygen uptake (VO2max). METHOD: Study subjects were women with type 2 DM and healthy individuals, who were paired by age group. Initial examinations were carried out in the form of body mass index, glucose at any time, ankle-brachial index, blood pressure, and pulse before the training test. Before being given a 400-meter road test, the subjects warmed up on a 20-meter track for 2 minutes. During warm-ups and training tests, the pulse is measured every 30 seconds. Systolic blood pressure is measured after warm-up and within 60 seconds of the training test. Test the 400-meter walk is carried out 2 times on different days.;, ]"

"Background: thyroid dysfunction is more likely to occur in diabetes mellitus patients than general population. Until now, no study has been done to find prevalence of hypothyroidism and hyperthyroidism in Indonesian diabetics. This study aimed to find the proportion and characteristics of thyroid dysfunction in Indonesian type 2 diabetes mellitus patients. Methods: a cross-sectional study was conducted in Endocrine and Diabetes Polyclinic, Department of Internal Medicine, Cipto Mangunkusumo Hospital from July to September 2015. This study include type 2 diabetes mellitus patients, age ≥ 18 year-old, willing to undergo thyroid laboratory testing. In this study, hypothyroidism defined as TSH more than 4.0 mIU/L, while hyperthyroidism is defined as TSH less than 0.4 mIU/L with eCLIA. Results: from 364 subjects who were recruited from Endocrine and Diabetes Polyclinic, Cipto Mangunkusumo Hospital, 303 subjects underwent this study until analysis. Two hundred and three (273) subjects (90.1%) were euthyroid, 7 subjects (2.31%) were hyperthyroid, and 23 subjects (7.59%) were hypothyroid. Majority of the patients had subclinical hypothyroidism (56.5% based on Zulewski and Billewicz Score and 65.2% based on fT4 laboratory result), while 42.9% and 71.4% subjects had clinical hyperthyroidism based on clinical appearance and fT4 laboratory result respectively. Conclusion: proportion of hypothyroidism was 7.59% and hyperthyroidism was 2.31%, while the proportion of total thyroid dysfunction was 9.9% among diabetics. It is suggested that screening for thyroid dyscfunction can be done in high risk condition as a part of comprehensive management in type 2 diabetes mellitus patients."